AzTrials
AzTrials

Brain InjuryGODWEANNCT02235376

Criteria of Extubation Failure of Brain Injured Patients. Elaboration of a Prognostic Score.

An observational study of Brain Injury, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Identification of criteria associated with extubation failure of brain injured patients. Elaboration of a prognostic score of extubation failure of brain injured patients. Read more about this study

Who is it for?
Ages 15 years and older
Conditions the study is for
Brain Injury
What is being tested?
weaning trial of mechanical ventilation
How many people
140 participants
Where
1 siteFrance
Study dates
Jun 2013to Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: brain injured patients

Who may be able to join

  • Adult brain injured patients ventilated eligible to discontinuation of mechanical ventilation
  • Stable respiratory and hemodynamic conditions
  • Ventilated patients for more than 48 hours
  • Adequate gaseous exchange (SpO2 ≥ 92% and respiratory rate ≤ 35/min, FiO2 ≤ 40%, positive end-expiratory pressure ≤ 5 cmH2O, pressure support ≤ 8 cmH2O, tidal volume ≥ 7mL/kg
  • Therapeutic extubation

Who cannot join

  • • Status epilepticus
  • Cerebrospinal infection
  • Patients under 15 years old
  • Mechanical ventilation of < 48 h
  • Spinal cord injury
  • Withdrawal of life support

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63003

Other trials in France

About this study

Identification of criteria associated with extubation failure of brain injured patients. Elaboration of a prognostic score of extubation failure of brain injured patients.

Read the detailed description

Prospective clinical study in ICU with brain injured ventilated patients eligible to extubation.

Identification of clinical and biological criteria associated with failure of extubation.

Elaboration of a prognostic score of extubation failure of brain injured patients, based on criteria previously identified with multivariate analysis.

Failure of extubation is defined by the need of re-intubation or the need for non-invasive ventilation within 48 hours or more after extubation.

Conditions
Brain Injury
Being tested
weaning trial of mechanical ventilation
Keywords
Critical Care, Brain injured patients, Mechanical Ventilation, Weaning, Extubation, Prognostic score, Clinical examination
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • weaning trial of mechanical ventilationOther

Study groups in NCT02235376
Study groupRoleWhat they receive
critical careNot described
Receives: Other: weaning trial of mechanical ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Failure of extubation defined by the need of reintubation or the need for non-invasive ventilation

    • Failure of extubation defined by the need of reintubation or the need for non-invasive ventilation within 48 hours or during ICU stay

    Measured: at day 2

Secondary outcomes (9)
  1. Severity scores (SAPS II, SOFA, GCS…) ) at patient admission in ICU

    Measured: at ady 1

  2. Cause of brain injury (traumatic, ischemic, hemorrhagic or post-operative) at patient admission in ICU

    Measured: at day 1

  3. Localisation of brain injury (hemispheric, supra- or sub-tentorial) at patient admission in ICU

    Measured: at day 1

  4. Complete neurological examination (Glasgow score, Coma Recovery Scale, FOUR score, cough, brain stem reflexes) just before extubation

    Measured: at day 1

  5. cardiologic history (cardiac insufficiency or ischemic cardiomyopathy) during ICU stay

    Measured: at day 1

  6. - Pulmonary examination (arterial gasometry, ventilatory parameters: mode, frequency, positive end expiratory pressure, inspiratory pressure, tidal volume, minute ventilation, oxygen level) just before extubation

    Measured: at day 1

  7. - Cause of extubation failure before 48 hours (respiratory, hemodynamic, aspiration, ...)

    Measured: at day 2

  8. Delay of extubation from intubation day (number of days)

    Measured: at day 1

  9. Glasgow Outcome Score (GOS)

    Measured: at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2014 (estimated)
  2. Study startJun 2013
  3. Primary completionSep 2015
  4. Study completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02235376
Sponsor's protocol ID
CHU-0201
Acronym
GODWEAN
Status last verified
Oct 2015
First submitted
28 Jul 2014
Last updated
15 Oct 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injury, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Failure of extubation defined by the need of reintubation or the need for non-invasive ventilation (time frame: at day 2). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in